Naturalistic, retrospective comparison between antidepressant therapy and atypical antipsychotic augmentation therapy for patients with major depressive disorder

被引:0
|
作者
Cho, Se Hoon [1 ]
Jae, Young Myo [1 ]
Jang, Sae Heon [1 ]
Baek, Dae Up [2 ]
Choi, Jin Hyuk [1 ]
机构
[1] Bong Seng Mem Hosp, Dept Psychiat, Busan, South Korea
[2] Dongrae Bong Seng Mem Hosp, Dept Psychiat, Busan, South Korea
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
PS78
引用
收藏
页码:73 / 74
页数:2
相关论文
共 50 条
  • [1] Modafinil as antidepressant augmentation therapy in major depressive disorder
    Thase, ME
    DeBattista, C
    Fava, M
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S210 - S211
  • [2] The effects of antidepressant monotherapy versus adjunctive therapy with an atypical antipsychotic in new-onset major depressive disorder
    Baek, Daeup
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2012, 16 : 16 - 16
  • [3] Aripiprazole for the augmentation of antidepressant therapy in inadequate responders diagnosed with major depressive disorder
    Hou, Y. M.
    Huang, L. C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S462 - S462
  • [4] Amisulpride augmentation vs. standard antidepressant therapy in major depressive disorder
    Grigorescu, G.
    Vasile, D.
    Vasiliu, O.
    Vasile, M. -L.
    Tudor, C.
    Cantemir, A.
    Zavoianu, M.
    Mangalagiu, A. G.
    Terpan, M.
    Grigorescu, R.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 149 - 149
  • [5] Atypical antipsychotic augmentation of mood stabilizer therapy in bipolar disorder
    Bowden, CL
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 : 12 - 19
  • [6] SOMATIC THERAPY FOR MAJOR DEPRESSIVE DISORDER - SELECTION OF AN ANTIDEPRESSANT
    PRESKORN, SH
    BURKE, M
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1992, 53 : 5 - 18
  • [7] Efficacy and safety of lisdexamfetamine dimesylate as augmentation therapy in adults with major depressive disorder treated with an antidepressant
    Trivedi, M. H.
    Patkar, A. A.
    Cutler, A. J.
    Richards, C.
    Lasser, R.
    Geibel, B.
    Gao, J.
    Sambunaris, A.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 192 - 193
  • [8] Efficacy and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
    Shin, D.
    Hong, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S300 - S300
  • [9] Adherence to augmentation therapy for the treatment of major depressive disorder
    Forma, Felicia
    Liberman, Joshua N.
    Rui, Pinyao
    Ruetsch, Charles
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (03) : 327 - 335
  • [10] Frequency of metabolic syndrome in obsessive compulsive disorder patients on antidepressant monotherapy vs antidepressant plus atypical antipsychotic combination therapy: a naturalistic, descriptive pilot study
    Savas, Esen
    Ozovaci, Arzu
    Kokacya, Mehmet Hanifi
    Altindag, Abdurrahman
    Virit, Osman
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 20 (04): : 307 - 313